Get the Stockscreener App
1.92
1.57%
0.01
After Hours:
1.92
Seer Inc stock is traded at $1.92, with a volume of 300.49K.
It is up +1.57% in the last 24 hours and down -2.51% over the past month.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
See More
Previous Close:
$1.91
Open:
$1.91
24h Volume:
300.49K
Relative Volume:
1.00
Market Cap:
$105.53M
Revenue:
$14.18M
Net Income/Loss:
$-82.66M
P/E Ratio:
-1.4769
EPS:
-1.3
Net Cash Flow:
$-50.80M
1W Performance:
-7.62%
1M Performance:
-2.51%
6M Performance:
-21.46%
1Y Performance:
+9.60%
1-Day Range:
$1.91
$1.9965
1-Week Range:
$1.91
$2.12
52-Week Range:
$1.56
$2.625
Seer Inc Stock (SEER) Company Profile
Name
Seer Inc
Sector
Industry
Phone
650-453-0000
Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
1.925 | 122.45M | 14.18M | -82.66M | -50.80M | -1.30 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 25.81B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.85 | 111.46B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 40.37M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.16 | 6.19B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
489.52 | 64.44B | 14.09B | 4.50B | 2.96B | 39.28 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-11-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Dec-29-20 | Initiated | BofA Securities | Neutral |
| Dec-29-20 | Initiated | Cowen | Outperform |
| Dec-29-20 | Initiated | JP Morgan | Overweight |
| Dec-29-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Seer Inc Stock (SEER) Latest News
Seer Inc. unveils advanced proteomics suite By Investing.com - Investing.com Canada
Seer Inc. unveils advanced proteomics suite - Investing.com Australia
Seer (SEER) Unveils Advanced Proteograph Product Suite | SEER St - GuruFocus
Seer Redefining Deep Unbiased Proteomics with Launch of New Prot - GuruFocus
Seer Redefining Deep Unbiased Proteomics with Launch of New - GlobeNewswire
New Proteograph ONE Platform Revolutionizes Protein Analysis: 1000+ Samples Per Week at 60% Lower Cost - Stock Titan
Have Seer Insiders Been Selling Stock? - simplywall.st
Seer Inc. Hold Rating: Balancing Impressive Revenue Growth with Market Uncertainties - TipRanks
Top Executives Unload Seer Stock in Major Transactions - TipRanks
D. E. Shaw & Co. Inc. Acquires 103,630 Shares of Seer, Inc. (NASDAQ:SEER) - Defense World
Cubist Systematic Strategies LLC Sells 46,541 Shares of Seer, Inc. (NASDAQ:SEER) - Defense World
Dimensional Fund Advisors LP Buys 5,000 Shares of Seer, Inc. (NASDAQ:SEER) - Defense World
Seer reiterates $17M–$18M 2025 revenue guidance amid strong Q1 instrument demand and large-scale study momentum - MSN
US$3.00: That's What Analysts Think Seer, Inc. (NASDAQ:SEER) Is Worth After Its Latest Results - simplywall.st
Seer, Inc. Reports Strong Q1 2025 Earnings - TipRanks
Barclays PLC Decreases Stake in Seer, Inc. (NASDAQ:SEER) - Defense World
Seer, Inc. (SEER) Reports Q1 Loss, Tops Revenue Estimates - MSN
Seer, Inc. (NASDAQ:SEER) Q1 2025 Earnings Call Transcript - Insider Monkey
Seer (SEER) Anticipates Revenue Growth in 2025 | SEER Stock News - GuruFocus
Seer Inc (SEER) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - Yahoo Finance
Seer, Inc. Reports Strong Q1 2025 Growth - TipRanks
Seer Q1 2025 Earnings Call Transcript - MarketBeat
Seer (SEER) Surpasses Q1 Revenue Expectations with Strong Perfor - GuruFocus
Earnings call transcript: Seer Q1 2025 sees strong revenue growth, stock jumps - Investing.com Australia
Seer Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Seer Inc (SEER) Q1 2025 Earnings: EPS of -$0.34 Beats Estimate, Revenue Surges to $4.2 Million - GuruFocus
Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook - The Manila Times
Seer, Inc. Reports Strong First Quarter 2025 Financial Results with $4.2 Million in Revenue - Nasdaq
SpaceWorks Enterprises Inc. Integrates AI into Spaceflight Planning and National Defense Initiatives with SEERai, Galorath's AI-Powered Cost Estimation Platform - StreetInsider
What To Expect From Seer Inc (SEER) Q1 2025 Earnings - GuruFocus
Indo-Asian News Service - Indo-Asian News Service (IANS)
Seer (SEER) Expected to Announce Earnings on Tuesday - Defense World
AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Geode Capital Management LLC Decreases Position in Seer, Inc. (NASDAQ:SEER) - Defense World
Renaissance Technologies LLC Acquires 179,568 Shares of Seer, Inc. (NASDAQ:SEER) - The AM Reporter
Seer (NASDAQ:SEER) Shares Down 2.5% – What’s Next? - Defense World
Seer to Report First Quarter 2025 Financial Results on May 13, 2025 | SEER Stock News - GuruFocus
Seer to Report First Quarter 2025 Financial Results on May 13, 2025 - GlobeNewswire
Seer, Inc. to Report Q1 2025 Financial Results on May 13, 2025 - Nasdaq
Seer Earnings Preview: Proteomics Pioneer Readies Q1 2025 Financial Results for May 13 Release - Stock Titan
Veracyte data joins NCI SEER database for research - Investing.com
Seer Medical saved by $40 million rescue deal from global investors, Breakthrough Victoria - SmartCompany
Cadwell invests in Australian company Seer Medical - Yahoo
Cadwell Makes a Strategic Investment in Seer Medical to Expand Home-Based Epilepsy Diagnostics | Newswise - Newswise
Cadwell Makes a Strategic Investment in Seer Medical to Expand Home-Based Epilepsy Diagnostics - Yahoo Finance
Metagenomi Leads The Charge With These 3 Penny Stocks - simplywall.st
Seer : Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference - MarketScreener
Corient Private Wealth LLC Acquires 13,200 Shares of Seer, Inc. (NASDAQ:SEER) - Defense World
Seer Inc (SEER) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
SEER LAUNCHES CARBON FOCUSED DIVISION TO PRODUCE LICENSED - GlobeNewswire
SEER LAUNCHES CARBON FOCUSED DIVISION TO PRODUCE LICENSED BIOCHAR, MONETIZE AND TOKENIZE ASSETS AND CARBON CREDITS AND DEVELOP TURBINE BLADE TREATMENT TECHNOLOGY - Yahoo
Seer Inc Stock (SEER) Financials Data
Revenue
Net Income
Cash Flow
EPS
Seer Inc Stock (SEER) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Farokhzad Omid | CEO AND CHAIR |
May 20 '25 |
Sale |
2.08 |
33,663 |
69,854 |
1,306,060 |
| Horn David R. | PRESIDENT & CFO |
Feb 04 '25 |
Sale |
2.24 |
3,550 |
7,940 |
476,961 |
| Farokhzad Omid | CEO AND CHAIR |
Feb 04 '25 |
Sale |
2.24 |
8,068 |
18,044 |
1,428,217 |
| Nishar Dipchand | Director |
Jun 14 '24 |
Sale |
1.78 |
12,109 |
21,512 |
79,457 |
1.89%
3.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):